These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28926061)

  • 1. Network-based modelling and percolation analysis of conformational dynamics and activation in the CDK2 and CDK4 proteins: dynamic and energetic polarization of the kinase lobes may determine divergence of the regulatory mechanisms.
    Verkhivker GM
    Mol Biosyst; 2017 Oct; 13(11):2235-2253. PubMed ID: 28926061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
    Czemeres J; Buse K; Verkhivker GM
    PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone.
    Stetz G; Tse A; Verkhivker GM
    PLoS One; 2017; 12(11):e0186089. PubMed ID: 29095844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.
    Chohan TA; Chen JJ; Qian HY; Pan YL; Chen JZ
    Mol Biosyst; 2016 Apr; 12(4):1250-68. PubMed ID: 26883408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of a ligand complexed with Cdk2/Cdk4 by computer simulation.
    Jiang Y; Zou J; Gui C
    J Mol Model; 2005 Nov; 11(6):509-15. PubMed ID: 15928920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational Equilibrium of CDK/Cyclin Complexes by Molecular Dynamics with Excited Normal Modes.
    Floquet N; Costa MG; Batista PR; Renault P; Bisch PM; Raussin F; Martinez J; Morris MC; Perahia D
    Biophys J; 2015 Sep; 109(6):1179-89. PubMed ID: 26255588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slower CDK4 and faster CDK2 activation in the cell cycle.
    Zhang W; Liu Y; Jang H; Nussinov R
    Structure; 2024 Aug; 32(8):1269-1280.e2. PubMed ID: 38703777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes.
    Wierød L; Rosseland CM; Lindeman B; Oksvold MP; Grøsvik H; Skarpen E; Huitfeldt HS
    Cell Prolif; 2007 Aug; 40(4):475-87. PubMed ID: 17635516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4.
    Park H; Yeom MS; Lee S
    Chembiochem; 2004 Dec; 5(12):1662-72. PubMed ID: 15505811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
    Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
    Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets.
    Zhang W; Liu Y; Jang H; Nussinov R
    JACS Au; 2024 May; 4(5):1911-1927. PubMed ID: 38818077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors.
    Rossi KA; Markwalder JA; Seitz SP; Chang CH; Cox S; Boisclair MD; Brizuela L; Brenner SL; Stouten PF
    J Comput Aided Mol Des; 2005 Feb; 19(2):111-22. PubMed ID: 16075305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Conformational Activation of CDK2 Kinase.
    Pellerano M; Tcherniuk S; Perals C; Ngoc Van TN; Garcin E; Mahuteau-Betzer F; Teulade-Fichou MP; Morris MC
    Biotechnol J; 2017 Aug; 12(8):. PubMed ID: 28430399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Break CDK2/Cyclin E1 interface allosterically with small peptides.
    Chen H; Zhao Y; Li H; Zhang D; Huang Y; Shen Q; Van Duyne R; Kashanchi F; Zeng C; Liu S
    PLoS One; 2014; 9(10):e109154. PubMed ID: 25290691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2.
    Li Y; Zhang J; Gao W; Zhang L; Pan Y; Zhang S; Wang Y
    Int J Mol Sci; 2015 Apr; 16(5):9314-40. PubMed ID: 25918937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why are the truncated cyclin Es more effective CDK2 activators than the full-length isoforms?
    Rath SL; Senapati S
    Biochemistry; 2014 Jul; 53(28):4612-24. PubMed ID: 24947816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
    Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
    Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.